23andMe board quits over plans to take DNA testing company private
All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave just one sitting member of the board,
23andMe Board Resigns in New Blow to DNA-Testing Company
All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne Wojcicki over her plan to take the company private.
Turmoil strikes 23andMe as board members resign in dispute with founder
The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health care and develop pharmaceuticals.
Every single member of the board just resigned from DNA tester 23andMe
Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday. The move is almost certainly the final nail in the coffin for the embattled company known for its mail-order DNA-testing kit.
Every Member of 23andMe's Board Except the CEO Just Resigned in Disgust
Nearly the entire board of directors for 23andMe has resigned — a move that apparently was news to its overly-optimistic chief executive.
23andMe Board resigns en masse amid CEO Anne Wojcicki's plans to take DNA testing company private
The board of directors at 23andMe, a leading DNA testing company, has resigned en masse amid disagreements over CEO Anne Wojcicki's plans to take the company private. The surprise move comes as Wojcicki seeks to take the company private in a deal valued at $4 billion.
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
23andMe Directors Resign as the CEO of the Genetic-Testing Company Seeks to Take It Private
All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company
Independent directors resign from 23andMe board after opposing move to privatize
The seven independent members of the board of personal genomics company 23andMe quit Tuesday amid opposition to CEO Anne Wojcicki’s plan to take the company private.
23andMe Board Resigns Amid Financial Struggles
I ranked 12 fast-food double cheeseburgers from worst to best, and my favorite was also a great value U.S. Troops Moved to Alaska Island Amid Russia Threat Why You Should Stick to the One-Tenth Rule When Buying a Car Kurt Russell's 5 Most Rewatchable Movies,
Hosted on MSN19h
23andMe Agrees to $30M Settlement That Could Pay $10,000 to Data Breach Victims
Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...
23andMe agrees to $30 million settlement over data breach that affected 6.9 million users
Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.
23andMe’s independent directors quit in clash with CEO over buyout plan
The directors said the decision comes after months of work that failed to result in an actionable plan that meets the ...
23andMe sees independent board directors quit en masse
Me, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 ...
Jewish Telegraphic Agency2d
23andMe agrees to $30M settlement over data breach that targeted Jewish and Chinese users
The genetic testing company 23andMe has agreed to pay $30 million to American plaintiffs to settle a lawsuit over a data ...